{
    "title": "Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ–PI3Kδ Dual Inhibitors",
    "id": "jm8b02014",
    "journal": "Journal of Medicinal Chemistry",
    "reactions": [
        {
            "text": "Modifications were evaluated at key locations on the chemotype: C-5 of the pyrrolotriazinone (R1), C-3 of the pyrrolidine (R2), and the hinge-binding region of the molecule (W). As shown in Table 1, when C5-Cl of 6 was changed to F or H, the resulting analogs 8 and 9, respectively, demonstrated 5.6-fold and 9-fold lower activities against PI3Kγ (in the Supporting Information, we compared the electrostatic surfaces of all three. See Figures S5 and S6.).",
            "product": "8",
            "reactants": "6, F"
        },
        {
            "text": "Modifications were evaluated at key locations on the chemotype: C-5 of the pyrrolotriazinone (R1), C-3 of the pyrrolidine (R2), and the hinge-binding region of the molecule (W). As shown in Table 1, when C5-Cl of 6 was changed to F or H, the resulting analogs 8 and 9, respectively, demonstrated 5.6-fold and 9-fold lower activities against PI3Kγ (in the Supporting Information, we compared the electrostatic surfaces of all three. See Figures S5 and S6.).",
            "product": "9",
            "reactants": "H"
        },
        {
            "text": "The balanced profile of compound 22 along with the ability to readily modulate the C-5 substituent led us to explore the SAR of the 2-aminopyrimidine as an effective hinge motif. As shown in Table 3, 23 demonstrated a reduced biochemical potency than 22 toward PI3Kγ and PI3Kδ with IC50 values of 0.182 and 0.059 μM, respectively. Replacing the nitrile of compound 22 with an alkyne resulted in 24, which maintained isoform PI3K activities and selectivity in both enzymatic and cellular assays; however, the rat liver microsomal (RLM) stability was only 8.9%. Changing nitrile of compound 22 to a methyl sulfone gave 25, which had a complete loss of activities. The introduction of a methyl ketone into the C-5 position of the pyrimidine yielded 26, which was both active and selective at PI3Kγ and PI3Kδ (IC50 at PI3Kα = 3.7 μM in enzyme and >10 μM in cell) as well as very potent on the inhibition of C5a and anti-IgM-induced Akt phosphorylation (IC50 = 0.011 ± 0.005 μM for PI3Kγ and 0.025 ± 0.009 μM for PI3Kδ).",
            "product": "24",
            "reactants": "22"
        },
        {
            "text": "The balanced profile of compound 22 along with the ability to readily modulate the C-5 substituent led us to explore the SAR of the 2-aminopyrimidine as an effective hinge motif. As shown in Table 3, 23 demonstrated a reduced biochemical potency than 22 toward PI3Kγ and PI3Kδ with IC50 values of 0.182 and 0.059 μM, respectively. Replacing the nitrile of compound 22 with an alkyne resulted in 24, which maintained isoform PI3K activities and selectivity in both enzymatic and cellular assays; however, the rat liver microsomal (RLM) stability was only 8.9%. Changing nitrile of compound 22 to a methyl sulfone gave 25, which had a complete loss of activities. The introduction of a methyl ketone into the C-5 position of the pyrimidine yielded 26, which was both active and selective at PI3Kγ and PI3Kδ (IC50 at PI3Kα = 3.7 μM in enzyme and >10 μM in cell) as well as very potent on the inhibition of C5a and anti-IgM-induced Akt phosphorylation (IC50 = 0.011 ± 0.005 μM for PI3Kγ and 0.025 ± 0.009 μM for PI3Kδ).",
            "product": "25",
            "reactants": "22",
            "reaction type": "Changing nitrile of compound 22 to a methyl sulfone"
        },
        {
            "text": "The balanced profile of compound 22 along with the ability to readily modulate the C-5 substituent led us to explore the SAR of the 2-aminopyrimidine as an effective hinge motif. As shown in Table 3, 23 demonstrated a reduced biochemical potency than 22 toward PI3Kγ and PI3Kδ with IC50 values of 0.182 and 0.059 μM, respectively. Replacing the nitrile of compound 22 with an alkyne resulted in 24, which maintained isoform PI3K activities and selectivity in both enzymatic and cellular assays; however, the rat liver microsomal (RLM) stability was only 8.9%. Changing nitrile of compound 22 to a methyl sulfone gave 25, which had a complete loss of activities. The introduction of a methyl ketone into the C-5 position of the pyrimidine yielded 26, which was both active and selective at PI3Kγ and PI3Kδ (IC50 at PI3Kα = 3.7 μM in enzyme and >10 μM in cell) as well as very potent on the inhibition of C5a and anti-IgM-induced Akt phosphorylation (IC50 = 0.011 ± 0.005 μM for PI3Kγ and 0.025 ± 0.009 μM for PI3Kδ).",
            "product": "26",
            "reactants": "methyl ketone"
        },
        {
            "text": "Compounds 30a–e were prepared starting with a coupling reaction between amide 29a–c and various substituted proline or azetidine carboxylic acids, followed by an intramolecular dehydration to produce 31a,e. The desired compounds were generated by two routes, depending on the nature of the R2 substituent. When R2 is not a hydroxyl, 31a,b and 31d,e were converted to 32a–e. After NBoc deprotection, 32a–e were treated with the halides of the selected hinge motif W in nucleophilic aromatic substitution (SnAr) reactions to give the final compounds 6–9, 11–12, 14, 16–24 and 26, as well as 25a and 36a,b as intermediates. If R2 is a hydroxyl, the compound was treated with diethylaminosulfur trifluoride (DAST) to introduce fluorine onto the pyrrolidine.",
            "product": "30",
            "reactants": "29a–c",
            "reaction type": "coupling"
        },
        {
            "text": "Compounds 30a–e were prepared starting with a coupling reaction between amide 29a–c and various substituted proline or azetidine carboxylic acids, followed by an intramolecular dehydration to produce 31a,e. The desired compounds were generated by two routes, depending on the nature of the R2 substituent. When R2 is not a hydroxyl, 31a,b and 31d,e were converted to 32a–e. After NBoc deprotection, 32a–e were treated with the halides of the selected hinge motif W in nucleophilic aromatic substitution (SnAr) reactions to give the final compounds 6–9, 11–12, 14, 16–24 and 26, as well as 25a and 36a,b as intermediates. If R2 is a hydroxyl, the compound was treated with diethylaminosulfur trifluoride (DAST) to introduce fluorine onto the pyrrolidine.",
            "product": "31",
            "reactants": "29a–c",
            "reaction type": "intramolecular dehydration"
        },
        {
            "text": "Compounds 30a–e were prepared starting with a coupling reaction between amide 29a–c and various substituted proline or azetidine carboxylic acids, followed by an intramolecular dehydration to produce 31a,e. The desired compounds were generated by two routes, depending on the nature of the R2 substituent. When R2 is not a hydroxyl, 31a,b and 31d,e were converted to 32a–e. After NBoc deprotection, 32a–e were treated with the halides of the selected hinge motif W in nucleophilic aromatic substitution (SnAr) reactions to give the final compounds 6–9, 11–12, 14, 16–24 and 26, as well as 25a and 36a,b as intermediates. If R2 is a hydroxyl, the compound was treated with diethylaminosulfur trifluoride (DAST) to introduce fluorine onto the pyrrolidine.",
            "product": "32a–e",
            "reactants": "31a,b, 31d,e"
        },
        {
            "text": "Compounds 30a–e were prepared starting with a coupling reaction between amide 29a–c and various substituted proline or azetidine carboxylic acids, followed by an intramolecular dehydration to produce 31a,e. The desired compounds were generated by two routes, depending on the nature of the R2 substituent. When R2 is not a hydroxyl, 31a,b and 31d,e were converted to 32a–e. After NBoc deprotection, 32a–e were treated with the halides of the selected hinge motif W in nucleophilic aromatic substitution (SnAr) reactions to give the final compounds 6–9, 11–12, 14, 16–24 and 26, as well as 25a and 36a,b as intermediates. If R2 is a hydroxyl, the compound was treated with diethylaminosulfur trifluoride (DAST) to introduce fluorine onto the pyrrolidine.",
            "product": "16–24, 6–9, 11–12, 25a, 14, 26",
            "reactants": "W, 32a–e",
            "reaction type": "nucleophilic aromatic substitution, SnAr"
        },
        {
            "text": "Compounds 30a–e were prepared starting with a coupling reaction between amide 29a–c and various substituted proline or azetidine carboxylic acids, followed by an intramolecular dehydration to produce 31a,e. The desired compounds were generated by two routes, depending on the nature of the R2 substituent. When R2 is not a hydroxyl, 31a,b and 31d,e were converted to 32a–e. After NBoc deprotection, 32a–e were treated with the halides of the selected hinge motif W in nucleophilic aromatic substitution (SnAr) reactions to give the final compounds 6–9, 11–12, 14, 16–24 and 26, as well as 25a and 36a,b as intermediates. If R2 is a hydroxyl, the compound was treated with diethylaminosulfur trifluoride (DAST) to introduce fluorine onto the pyrrolidine.",
            "product": "36a,b",
            "reactants": "32a–e",
            "reaction type": "nucleophilic aromatic substitution, SnAr"
        },
        {
            "text": "When W is 4-(2-amino-5-bromo)pyrimidinyl, 25a was coupled with sodium methanesulfinate to give 25. 36a,b could be converted to compounds 27–28 by oxidation, followed by the displacement of sulfonyl with NH2 (Scheme 2).",
            "product": "25",
            "reactants": "sodium methanesulfinate, 25a"
        },
        {
            "text": "To a solution of 1-amino-3-chloro-1H-pyrrole-2-carboxamide (700 mg, 4.40 mmol) and (S)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid (1040 mg, 4.84 mmol) in THF was added EDC·HCl (950 mg, 4.95 mmol). The reaction mixture was stirred at room temperature for 3.5 h, then was diluted with water, and extracted with EtOAc. The combined organic layers were dried over anhydrous Na2SO4 and concentrated to yield the 30a as a white solid, which was used for the next step without further purification (1.25 g, 80%).",
            "product": "30a",
            "reactants": "(S)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, EDCHCl, 1-amino-3-chloro-1H-pyrrole-2-carboxamide",
            "temperature": "room",
            "time": "3.5 h",
            "solvent": "water, THF"
        },
        {
            "text": "A mixture of 31a (850 mg, 2.51 mmol), phenylboronic acid (613 mg, 5.02 mmol), molecular sieves (4 Å, 2 g), Cu(OAc)2, (915 mg, 5.02 mmol), and pyridine (1.00 mL, 12.55 mmol) in dry DCM (30 mL) was stirred overnight at room temperature under dry air. The mixture was concentrated in vacuo and purified by flash chromatography, eluting with 0–100% gradient of MeOH in H2O, to yield 32a as a white solid (250 mg, 24%).1H NMR (400 MHz, DMSO-d6) δ 7.67 (d, J = 2.8 Hz, 0.6H), 7.65 (d, J = 2.8 Hz, 0.4H), 7.62–7.46 (m, 4H), 7.33 (d, J = 7.2 Hz, 0.4H), 7.25 (d, J = 7.6 Hz, 0.6H), 6.66–6.63 (m, 1H), 4.21–4.17 (m, 0.4H), 4.16–4.13 (m, 0.6H), 3.46–3.36 (m, 1H), 3.25–3.17 (m, 1H), 2.12–1.64 (m, 4H), 1.34 (s, 3H), 1.25 (s, 6H).",
            "product": "32a",
            "reactants": "phenylboronic acid, Cu(OAc)2, pyridine, 31a",
            "temperature": "room",
            "time": "overnight",
            "solvent": "DCM"
        },
        {
            "text": "The residue (40 mg, 0.13 mmol) was dissolved in n-BuOH (3 mL), and then 6-chloro-9H-purine (22 mg, 0.14 mmol) and Et3N (0.10 mL, 0.65 mmol) were added. The reaction mixture was refluxed for 2 h. The mixture was concentrated to remove n-BuOH. The resulting residue was purified by flash chromatography, eluted with 0–100% gradient of MeOH in H2O, to yield the target compound 6 as a white solid (35 mg, 63%).",
            "product": "6",
            "reactants": "Et3N, 6-chloro-9H-purine",
            "temperature": "refluxed",
            "time": "2 h",
            "solvent": "n-BuOH"
        },
        {
            "text": "To a mixture of 25a [W = 4-(2-amino-5-bromo)pyrimidinyl, R1 = Cl, R3 = H, n= 0] (prepared by a procedure similar to that described for the synthesis of compound 6, 50 mg, 0.110 mmol) in toluene (10 mL), were added sodium methanesulfinate (27 mg, 0.260 mmol), Pd2(dba)3 (24 mg, 0.026 mmol), Xantphos (31 mg, 0.052 mmol), and K3PO4 (56 mg, 0.260 mmol). The reaction mixture was purged by N2 and then stirred at 120 °C under the microwave condition for 6 h. After cooling to room temperature, the mixture was concentrated and purified by flash chromatography to give 25 (5 mg, 10%) as a white solid.",
            "product": "25",
            "reactants": "n= 0, R3 = H, R1 = Cl, 25a [W = 4-(2-amino-5-bromo)pyrimidinyl",
            "solvent": "toluene",
            "catalyst": "Pd2(dba)3"
        },
        {
            "text": "1-(2-amino-4-chloropyrimidin-5-yl)ethan-1-one: To a solution of 1-(4-chloro-2-(methylthio)pyrimidin-5-yl)ethan-1-one (1 g, 5 mmol) in DCM (60 mL) was added m-CPBA (3.5 g, 20 mmol). The resulting mixture was stirred at room temperature for 12 h. Then, cooled to −5 °C, the reaction mixture, bubbled with NH3, was stirred at −5 °C for 1 h. The precipitate was formed and filtered out. The filtrate was concentrated and purified by flash chromatography, eluting with 0–100% gradient of MeOH in H2O, to give 1-(2-amino-4-chloropyrimidin-5-yl)ethan-1-one as a white solid (650 mg, 76%).",
            "product": "1-(2-amino-4-chloropyrimidin-5-yl)ethan-1-one",
            "reactants": "1-(4-chloro-2-(methylthio)pyrimidin-5-yl)ethan-1-one, NH3, m-CPBA",
            "temperature": "room",
            "time": "12 h",
            "solvent": "DCM"
        },
        {
            "text": "26 was prepared by a procedure similar to that described for the synthesis of compound 6 using 1-(2-amino-4-chloropyrimidin-5-yl)ethan-1-one as the material instead of 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile. Purity: 99.7%. MS (m/z): 436.0 (M + H)+. 1H NMR (400 MHz, DMSO-d6) δ 8.42 (s, 1H), 7.71–7.47 (m, 5H), 7.39–7.36 (m, 1H), 6.82 (s, 2H), 6.62 (d, J = 3.0 Hz, 1H), 4.87–4.75 (m, 1H), 4.15–4.08 (m, 1H), 3.29–3.28 (m, 1H), 2.43–2.35 (m, 1H), 2.23 (s, 3H), 2.03-1.75 (m, 1H).",
            "product": "26",
            "reactants": "1-(2-amino-4-chloropyrimidin-5-yl)ethan-1-one"
        }
    ]
}